Torrent Pharmaceuticals Ltd. | TORNTPHARM | NSE - Pharmaceuticals
INR in Million. Fiscal year ends in March. Figures are consolidated and restated..
Upgrade Membership to see 10 year accurate financial statements.
Chart | 2017 | 2018 | 2019 | 2020 | 2021 | |
---|---|---|---|---|---|---|
Cash and cash equiva... |
| 8,937 | 8,673 | 8,160 | 6,667 | 6,040 |
Short-term investment |
| 8,036 | 4,923 | 3,514 | 0.2 | 1,390 |
Accounts receivables |
| 13,442 | 12,535 | 14,357 | 16,493 | 15,230 |
Inventories |
| 15,592 | 19,663 | 19,352 | 21,482 | 26,810 |
Deferred income taxes |
| 818 | 0 | 0 | 0 | 0 |
Other current assets |
| 7,017 | 6,830 | 4,993 | 5,429 | 5,750 |
Total current assets |
| 53,841 | 52,623 | 50,375 | 50,071 | 55,220 |
Gross property plant... |
| 18,714 | 24,168 | 28,007 | 28,179 | 27,580 |
Accumulated Depriciat... |
| 0 | 0 | 0 | 0 | 0 |
Net property, plant and Eq... |
| 18,714 | 24,168 | 28,007 | 28,179 | 27,580 |
Work in Progress |
| 5,195 | 4,232 | 4,793 | 5,766 | 7,450 |
Miscellaneous Investment |
| 23 | 236 | 1,508 | 1,307 | 960 |
Deferred income taxes |
| 3,099 | 3,662 | 4,902 | 6,221 | 4,770 |
Intangible assets |
| 16,575 | 52,631 | 47,501 | 43,730 | 39,840 |
Goodwill |
| 1,595 | 3,985 | 3,348 | 3,421 | 3,410 |
Other long-term assets |
| 2,207 | 894 | 775 | 1,683 | 1,520 |
Total non-current assets |
| 47,408 | 89,808 | 90,834 | 90,307 | 85,530 |
Total assets |
| 101,249 | 142,431 | 141,209 | 140,378 | 140,750 |
Short-term debt |
| 0 | 16,256 | 9,341 | 10,909 | 7,040 |
Accounts Payable... |
| 22,979 | 20,482 | 20,967 | 20,769 | 20,670 |
Provisions |
| 1,937 | 3,767 | 4,932 | 4,537 | 4,310 |
Taxes Payable |
| 0 | 0 | 0 | 0 | 540 |
Deferred Revenues |
| 0 | 0 | 0 | 0 | 0 |
Capital Leases |
| 0 | 0 | 0 | 0 | 0 |
Other current liabilities |
| 6,696 | 11,517 | 16,413 | 18,608 | 16,350 |
Total current liabilities |
| 31,612 | 52,022 | 51,653 | 54,822 | 48,910 |
Long-term debt |
| 22,408 | 41,115 | 39,129 | 33,039 | 29,410 |
Investments Liabilities |
| 0 | 0 | 0 | 0 | 0 |
Deferred tax liabilities |
| 1,014 | 0.4 | 75 | 0 | 0 |
Provisions |
| 2,630 | 2,867 | 2,885 | 3,383 | 3,700 |
Capital Leases |
| 0 | 0 | 0 | 0 | 0 |
Other longterm liabilities |
| 79 | 202 | 223 | 902 | 350 |
Total non-current liabilities |
| 26,132 | 44,183 | 42,313 | 37,324 | 33,460 |
Total liabilities |
| 57,744 | 96,205 | 93,966 | 92,146 | 82,370 |
Share Capital |
| 846 | 846 | 846 | 846 | 850 |
Share premium |
| 0 | 0 | 0 | 0 | 0 |
Retained earnings |
| 42,655 | 45,376 | 46,397 | 47,386 | 57,530 |
Accumulated other equity |
| 0 | 0 | 0 | 0 | 0 |
Preferred Stock |
| 0 | 0 | 0 | 0 | 0 |
Minority Interest |
| 5 | 5 | 0 | 0 | 0 |
Total Equity |
| 43,506 | 46,227 | 47,244 | 48,232 | 58,380 |
Total Liabilities and Equity |
| 101,250 | 142,432 | 141,209 | 140,378 | 140,750 |
Cash per Share |
| Upgrade | Upgrade | Upgrade | Upgrade | Upgrade |
Cash, Current Inv Per share |
| Upgrade | Upgrade | Upgrade | Upgrade | Upgrade |